{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:01:20Z","timestamp":1792414880869,"version":"4.4.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Although recent evidence suggests that myeloid clonal hematopoiesis (M-CH) may influence lymphoma clinical outcome, its impact in mantle cell lymphoma (MCL) remains unclear. Here, we report a comprehensive next-generation sequencing\u2013based analysis of the M-CH mutational landscape at baseline and follow-up in patients enrolled in the Fondazione Italiana Linfomi MCL0208 phase 3 trial, evaluating lenalidomide maintenance vs observation after chemoimmunotherapy and autologous stem cell transplantation (ASCT) in untreated young patients with MCL. Overall, 254 of 300 (85%) enrolled patients (median age, 57 years [range, 32-66]) had a baseline sample available for CH analysis. Using stringent criteria, at least 1 mutation involving M-CH candidate genes was described in 34 patients (13%), with DNMT3A being the most frequently mutated gene (54%). After a median follow-up of 7 years, the presence of large CH clones (variant allele frequency of \u226510%) predicted worse progression-free survival (hazard ratio [HR], 2.93; 95% confidence interval [CI] 1.36-6.31; P\u00a0=\u00a0.006) and overall survival (HR, 3.02 [1.21-7.55]; P\u00a0=\u00a0.018) compared with patients with CH. Importantly, the competing risks analysis demonstrates that the worse clinical outcome associated with M-CH large clones is linked to MCL progression (P\u00a0&amp;lt; .05). Moreover, large M-CH clones showed longer time to hematological recovery after ASCT than the remaining cohort (P\u00a0=\u00a0.026). In conclusion, we showed for the first time that large CH clones might associate with unfavorable clinical impact in patients with MCL. This trial was registered at www.clinicaltrialsregister.eu as EudraCT (2009-012807-25) and www.ClinicalTrials.gov as #NCT02354313.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014948","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T21:59:19Z","timestamp":1736891959000},"page":"1805-1815","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3899-5755","authenticated-orcid":false,"given":"Simone","family":"Ragaini","sequence":"first","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"},{"name":"2Hematology Unit, Azienda Ospedaliero-Universitaria \u201cCitt\u00e0 della Salute e della Scienza di Torino,\u201d Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-3756","authenticated-orcid":false,"given":"Anna","family":"Galli","sequence":"additional","affiliation":[{"name":"3Department of Hematology Oncology, IRCCS San Matteo Hospital Foundation, Pavia, Italy"},{"name":"4Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-0337","authenticated-orcid":false,"given":"Elisa","family":"Genuardi","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Gandossini","sequence":"additional","affiliation":[{"name":"3Department of Hematology Oncology, IRCCS San Matteo Hospital Foundation, Pavia, Italy"},{"name":"4Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Alessandria","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora Maria","family":"Civita","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1901-2805","authenticated-orcid":false,"given":"Andrea","family":"Evangelista","sequence":"additional","affiliation":[{"name":"5Unit of Clinical Epidemiology, Azienda Ospedaliera Universitaria Citt\u00e0 della Salute e della Scienza and Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Amaducci","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"},{"name":"2Hematology Unit, Azienda Ospedaliero-Universitaria \u201cCitt\u00e0 della Salute e della Scienza di Torino,\u201d Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Stefoni","sequence":"additional","affiliation":[{"name":"6IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \u201cSer\u00e0gnoli,\u201d Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2047-1099","authenticated-orcid":false,"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"},{"name":"2Hematology Unit, Azienda Ospedaliero-Universitaria \u201cCitt\u00e0 della Salute e della Scienza di Torino,\u201d Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-6752","authenticated-orcid":false,"given":"Filippo","family":"Ballerini","sequence":"additional","affiliation":[{"name":"7IRCCS Ospedale Policlinico San Martino, Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Puccini","sequence":"additional","affiliation":[{"name":"8Hematology Unit, Careggi University Hospital, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-1979","authenticated-orcid":false,"given":"Daniele","family":"Vallisa","sequence":"additional","affiliation":[{"name":"9Hematology Unit, Department of Oncology and Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6302-0488","authenticated-orcid":false,"given":"Mariagrazia","family":"Michieli","sequence":"additional","affiliation":[{"name":"10High Dose Chemotherapy and Cellular Therapies Unit, IRCCS Centro di Riferimento Oncologico di Aviano, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-5080","authenticated-orcid":false,"given":"Anna","family":"Pascarella","sequence":"additional","affiliation":[{"name":"11Hematology Unit, Ospedale dell'Angelo, Mestre-Venezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-9754","authenticated-orcid":false,"given":"Angelo","family":"Palmas","sequence":"additional","affiliation":[{"name":"12Struttura Complessa Ematologia, Ospedale San Francesco, Azienda Sanitaria Locale Nuoro, Nuoro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Patti","sequence":"additional","affiliation":[{"name":"13Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-8325","authenticated-orcid":false,"given":"Elisa","family":"Lucchini","sequence":"additional","affiliation":[{"name":"14Unit\u00e0 Complessa Operativa Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Careddu","sequence":"additional","affiliation":[{"name":"15Ematologia, AOU Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Merli","sequence":"additional","affiliation":[{"name":"16Dipartimento di Oncologia ed Ematologia, Universit\u00e0 degli Studi di Milano, Policlinico di Milano, Ospedale Maggiore, Fondazione IRCCS Ca Granda, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Postorino","sequence":"additional","affiliation":[{"name":"17Hematology Unit, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Boccomini","sequence":"additional","affiliation":[{"name":"18Stuttura Complessa Ematologia, Azienda Ospedaliero-Universitaria Citt\u00e0 della Salute e della Scienza di Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-5115","authenticated-orcid":false,"given":"Monica","family":"Balzarotti","sequence":"additional","affiliation":[{"name":"19Unit\u00e0 Operativa di Ematologia, IRCCS Humanitas Research Hospital, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio Ruggero","family":"Zilioli","sequence":"additional","affiliation":[{"name":"20Division of Hematology, Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-2450","authenticated-orcid":false,"given":"Maria","family":"Gomes da Silva","sequence":"additional","affiliation":[{"name":"21Department of Hematology, Portuguese Institute of Oncology, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7299-6770","authenticated-orcid":false,"given":"Benedetto","family":"Bruno","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"},{"name":"2Hematology Unit, Azienda Ospedaliero-Universitaria \u201cCitt\u00e0 della Salute e della Scienza di Torino,\u201d Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-9000","authenticated-orcid":false,"given":"Ettore","family":"Rizzo","sequence":"additional","affiliation":[{"name":"22enGenome, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ladetto","sequence":"additional","affiliation":[{"name":"23Hematology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy"},{"name":"24Department of Translational Medicine, University of Eastern Piedmont, Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-1611","authenticated-orcid":false,"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[{"name":"3Department of Hematology Oncology, IRCCS San Matteo Hospital Foundation, Pavia, Italy"},{"name":"4Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9711-1502","authenticated-orcid":false,"given":"Simone","family":"Ferrero","sequence":"additional","affiliation":[{"name":"1Department of Molecular Biotechnologies and Health, University of Torino, Torino, Italy"},{"name":"2Hematology Unit, Azienda Ospedaliero-Universitaria \u201cCitt\u00e0 della Salute e della Scienza di Torino,\u201d Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"11","key":"2025042208414497000_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"6465","key":"2025042208414497000_bib2","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science (1979)"},{"issue":"26","key":"2025042208414497000_bib3","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"2025042208414497000_bib4","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2025042208414497000_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"issue":"14","key":"2025042208414497000_bib6","first-page":"1606","article-title":"Clonal hematopoiesis and non-hematologic disorders","volume":"136","author":"Jaiswal","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2025042208414497000_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ajh.26465","article-title":"Association of clonal hematopoiesis mutations with clinical outcomes: a systematic review and meta-analysis","volume":"97","author":"Nowakowska","year":"2022","journal-title":"Am J Hematol"},{"issue":"14","key":"2025042208414497000_bib8","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1182\/bloodadvances.2024013228","article-title":"Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis","volume":"8","author":"Singh","year":"2024","journal-title":"Blood Adv"},{"issue":"10","key":"2025042208414497000_bib9","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","article-title":"Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms","volume":"4","author":"Lewis","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2025042208414497000_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2643-3230.BCD-20-0203","article-title":"Dissecting clonal hematopoiesis in tissues of patients with classic Hodgkin lymphoma","volume":"2","author":"Venanzi","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"7","key":"2025042208414497000_bib11","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/bloodadvances.2021004926","article-title":"Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenstr\u00f6m macroglobulinemia","volume":"6","author":"Tahri","year":"2022","journal-title":"Blood Adv"},{"issue":"14","key":"2025042208414497000_bib12","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2025042208414497000_bib13","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/s41375-020-0795-z","article-title":"Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study","volume":"34","author":"Husby","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"2025042208414497000_bib14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41375-024-02258-y","article-title":"Clonal hematopoiesis\u2013derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders","volume":"38","author":"Awada","year":"2024","journal-title":"Leukemia"},{"issue":"22","key":"2025042208414497000_bib15","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.2019003539","article-title":"Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL","volume":"135","author":"Eskelund","year":"2020","journal-title":"Blood"},{"issue":"12","key":"2025042208414497000_bib16","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1038\/s41375-022-01725-8","article-title":"Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL","volume":"36","author":"Husby","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"2025042208414497000_bib17","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2352-3026(20)30358-6","article-title":"Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial","volume":"8","author":"Ladetto","year":"2021","journal-title":"Lancet Haematol"},{"issue":"12","key":"2025042208414497000_bib18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood.2021014270","article-title":"Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma","volume":"140","author":"Ferrero","year":"2022","journal-title":"Blood"},{"issue":"D1","key":"2025042208414497000_bib25","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"25","key":"2025042208414497000_bib19","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"issue":"13","key":"2025042208414497000_bib20","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/bloodadvances.2019001350","article-title":"Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis","volume":"4","author":"Hill","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2025042208414497000_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41375-024-02226-6","article-title":"Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche","volume":"38","author":"Winter","year":"2024","journal-title":"Leukemia"},{"issue":"12","key":"2025042208414497000_bib22","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/ajh.26726","article-title":"Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma","volume":"97","author":"Lackraj","year":"2022","journal-title":"Am J Hematol"},{"issue":"11","key":"2025042208414497000_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"issue":"16","key":"2025042208414497000_bib24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood.2021014956","article-title":"Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms","volume":"140","author":"Sperling","year":"2022","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/8\/1805\/2367614\/blooda_adv-2024-014948-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/8\/1805\/2367614\/blooda_adv-2024-014948-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:41:54Z","timestamp":1745325714000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/8\/1805\/535062\/Large-clones-of-clonal-hematopoiesis-affect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,4,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014948","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}